| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.34 | 4e-07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-06 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |